As per the research report, the North American Catheter Stabilization Devices Market Size is valued at USD 400.03 million in 2022 and expected to reach a CAGR of 7.14%, to grow from USD 564.75 million by 2027 during the forecast period 2022 to 2027.
Catheter stabilization devices are being developed in North America to reduce the risk of phlebitis, catheter migration, dislodgement, and catheter-related problems. In addition, Needlestick injuries are also reduced when catheter stabilizing devices are used.
The most significant factor is that these devices are most commonly utilized during cardiovascular surgeries, general surgeries, cancer treatment treatments, and other procedures. In the recent past, hospitals, ambulatory surgery centers, and other healthcare institutions have used advanced stabilizing devices to lower the prevalence of catheter-related problems during surgical procedures.
The essential point is that crucial manufacturers involved in catheter stabilization device production have introduced a variety of unique catheter stabilization devices to the market. Therefore, introducing such new devices is expected to support and drive the catheter stabilization device market expansion over the forecast period.
Another essential feature is that the novel device reduces catheter movement in the vasculature, limits skin contact with the patient connector, preserves the catheter insertion angle, and enhances stabilization with fewer catheter-related problems.
Various government organization's usage of catheter stabilization devices to minimize catheter-related infections is projected to boost demand for these devices and propel the worldwide catheter stabilization devices market forward.
Because of their widespread usage in illness diagnosis and treatment, catheters have become an essential part of the medical system. Medication delivery, parenteral feeding, IV fluid administration, and hemodynamic status monitoring are all done with these devices.
The use of catheter stabilization devices is expected to benefit from a favorable regulatory environment. The rigorous requirements regarding poor intravenous catheter maintenance may stifle expansion, while strict government controls maintain the availability of superior-quality and safe items, boosting demand throughout the study period. High dangers connected with catheter stabilizing devices, on the other hand, may limit its growth to some extent.
This research report on the North America Catheter Stabilization Devices Market has been segmented and sub-segmented into the following categories.
By End User:
Geographically, the catheter stabilization devices market in North America is predicted to increase dramatically, owing to the high prevalence of life-threatening conditions such as cancer and heart disease in the region.
The U.S Catheter Stabilization Devices Market is expected to grow significantly due to the high prevalence of these disorders. As a result, demand for catheter stabilization devices during treatment is predicted to rise.
According to American Cancer Society data from 2017, cancer is the top cause of death in the United States, with 4.3 million new cancer diagnoses and 2.8 million cancer deaths per year.
The Centers for Disease Control & Prevention issued some guidelines in countries like the USA and Canada for healthcare professionals who insert intravascular catheters and persons responsible for surveillance and control infections in hospitals and clinics.
The Canada Catheter Stabilization Devices Market is forecasted to reach a certain CAGR due to the rising frequency of cardiovascular and lifestyle illnesses and the increasing number of clinical procedures, which are predicted to increase demand for catheters stabilization devices in hospitals and other healthcare facilities.
KEY MARKET PLAYERS
Companies playing a dominant role in the North America Catheter Stabilization Devices Market profiled in this report are Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), C. R. Bard, Inc (U.S.), Merit Medical Systems, Inc. (U.S.), Smiths Group plc (U.K.), Centurion Medical Products (U.S.), 3M Company (U.S.), ConvaTec Inc. (U.S.), Medtronic plc (U.S.), and M.C. Johnson Company, Inc. (U.S.).,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org